Hematologic Malignancies Services Available In Virginia
-
Manufactured by Foundation Medicine, Inc.based in USA
Discover tissue AND blood-based FDA-approved comprehensive genomic profiling testing for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. ...
-
based in USA
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this paradigm is limited by the expression of tumor targets on healthy cells, resulting in on-target toxicity. ...
-
based in USA
Cytogenetics is the study of normal and abnormal chromosomes in relation to disease. Sometimes called chromosome analysis or karyotyping, cytogenetic tests are used to gain diagnostic and prognostic insights regarding solid tumor cancers and hematologic malignancies, which can be the result of chromosome rearrangements or altered chromosome ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you